REGN

920.6900.19%
AJ

Andrew J. Murphy

Executive VP of Research & Co-Chief Scientific Officer

Dr. Andrew J. Murphy, also known as Drew, Ph.D. has been Executive Vice President of Research at Regeneron Pharmaceuticals, Inc since January 2019 and also serves as Co-Chief Scientific Officer since 2025 and served as its Senior Vice President of Research - Regeneron Laboratories since January 2013 until January 2019. Dr. Murphy previously served as Director, Genomics & Bioinformatics at Regeneron Pharmaceuticals. Dr. Murphy joined Regeneron in 1999. He Joined Regeneron in 1999 as Director of Genomics and Bioinformatics. He was later named Vice President of Gene Discovery and Bioinformatics in 2001, Vice President of Target Discovery in 2005. Dr. Murphy is a co-inventor of several of Regeneron's key technologies - VelociGene® and VelocImmune® - and continues to lead several Technology Centers and Therapeutic Focus Areas. Prior to joining Regeneron. He received his B.S. in Molecular Biology at the University of Wisconsin and his Ph.D. in Human Genetics from Columbia University, College of Physicians and Surgeons.

Positions